Article Details
Retrieved on: 2025-04-14 16:01:51
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights Eyestem Research's promising phase 1 trial results of Eyecyte-RPE for treating geographic atrophy, an advanced form of AMD. This stem cell therapy shows potential in improving vision and could reshape AMD treatment.
Article found on: pharmafile.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here